LEFT VENTRICULAR DYSFUNCTION
Clinical trials for LEFT VENTRICULAR DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new LEFT VENTRICULAR DYSFUNCTION trials appear
Sign up with your email to follow new studies for LEFT VENTRICULAR DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for long COVID heart sufferers? major trial underway
Disease control OngoingThis study tests whether a combination of anti-inflammatory and heart-protecting drugs can reduce symptoms and prevent heart damage in people with Long COVID. About 279 adults with ongoing heart symptoms and signs of heart inflammation on MRI will receive either the drug combo or…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: PHASE3 • Sponsor: Valentina Puentmann • Aim: Disease control
Last updated May 26, 2026 04:42 UTC
-
New heart pump device tested in High-Risk surgery patients
Disease control OngoingThis study looks at how safe and effective the Impella 5.5 heart pump is for people with weak hearts who need high-risk heart surgery. About 123 patients with severe heart failure will take part. The goal is to see if the pump helps prevent serious problems like death, stroke, or…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
Heart pump device could boost outcomes in High-Risk patients
Disease control OngoingThis study looks at whether using the Impella heart pump during a high-risk procedure to open blocked arteries can help people with weak hearts feel better and live longer compared to standard care. About 1,250 adults with reduced heart function and complex coronary artery diseas…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Heart pump may save lives in High-Risk surgery
Disease control OngoingThis study tests whether using the Impella 5.5 heart pump during high-risk heart surgery helps people with severely weakened hearts. About 100 participants will receive the pump to support their heart function during and after surgery. The goal is to see if it reduces death, stro…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: NA • Sponsor: Abiomed Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Heart repair stem cell study pulled before it started
Disease control TerminatedThis study aimed to test if stem cells from umbilical cords, delivered through a thin tube into the heart, could safely help people with severe heart damage after a major heart attack. The goal was to improve heart function and reduce complications. However, the study was withdra…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Phase: PHASE1 • Sponsor: Shanghai Life Science & Technology • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Can a simple test predict sudden cardiac arrest?
Knowledge-focused OngoingThis study follows over 5,700 people with coronary artery disease to find blood or ECG markers that can predict sudden cardiac death. The goal is to identify those at highest risk so they can get life-saving treatments like defibrillators. Participants have mild to moderate heart…
Matched conditions: LEFT VENTRICULAR DYSFUNCTION
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 04:34 UTC